arrow_back Back to App

Tick Act Reauthorization: Reduced Funding for Vector-Borne Disease Programs

This act reauthorizes programs to combat tick-borne and other vector-borne diseases, but with reduced funding. This means the government will have less money for research, prevention, and treatment of these diseases from 2026 to 2030. This could impact the support available to local health departments and the overall strategy for addressing public health threats.
Key points
Reduced funding for national strategy and regional centers of excellence in vector-borne disease from $10 million to $8 million annually for fiscal years 2026-2030.
Decreased enhanced support for health departments addressing vector-borne diseases from $20 million to $19 million annually for fiscal years 2026-2030.
Changes to the composition of the Tick-Borne Disease Working Group, potentially affecting future initiatives.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2294
Sponsor: Sen. Collins, Susan M. [R-ME]
Process start date: 2025-07-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Kay Hagan Tick Reauthorization Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2294.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-07-15.

What are the main provisions?

Key points include:

  • Reduced funding for national strategy and regional centers of excellence in vector-borne disease from $10 million to $8 million annually for fiscal years 2026-2030.
  • Decreased enhanced support for health departments addressing vector-borne diseases from $20 million to $19 million annually for fiscal years 2026-2030.
  • Changes to the composition of the Tick-Borne Disease Working Group, potentially affecting future initiatives.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Collins, Susan M. [R-ME].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health